Omnipaque is a low-osmolar, nonionic, contrast medium with a broad range of indications, for example intravascular diagnostic procedures such as coronary angiography, spinal cord imaging, and body cavity procedures including shoulder and knee joints. Omnipaque is approved for use in adults and children, and is available in a wide variety of packagings.

See also Nonionic Contrast Agents.

Optiray® is a radiographic contrast agent. Optiray® is available in concentrations from 160 to 350 mg/mL organically bound iodine. Optiray® solutions have osmolalities 1.2 to 2.8 times that of plasma (285 mOsm/kg water).
Optiray® 160 is recommended for intraarterial digital subtraction angiography (IA-DSA).
See also Single-Head Contrast Media Injector, Dual-Head CT Power Injector, Syringeless CT Power Injector.

Reno-30® is a radiopaque contrast agent indicated for retrograde or ascending pyelography. Retrograde pyelography does not include systemic administration of contrast media, so the risk of adverse reactions is extremely rare.

Reno-60® is radiopaque contrast agent with a wide range of indications. Reno-60 should be at body temperature when injected and may need to be warmed before use. Following intravascular injection, iodinated contrast materials are transported through the bloodstream to the kidneys and excreted by glomerular filtration.

Sinografin® (diatrizoate meglumine and iodipamide meglumine) is a contrast agent indicated for use in hysterosalpingography. Intrauterine used contrast agents have few known pharmacological effects. Most of the medium within the uterine cavity is discharged immediately after finishing of the procedure and the contrast medium retained is completely absorbed.